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Summary
Objectives: To investigate and characterize Mycobacterium avium subspecies paratuberculosis
(MAP) in patients with Crohn’s disease, attendants of animals with suspected infection, and
healthy humans, using multiple diagnostic tests.
Methods: A total of 119 samples (35 stool, 76 serum, three blood clots, and five biopsies) were
collected from five patients with Crohn’s disease, eight attendants of animals with Johne’s
disease, and 93 apparently normal control subjects (Agra region) from North India. Samples were
screened for the presence of MAP by smear examination, culture of stool, blood clot and biopsies,
and ELISA. Colonies obtained by culture were further characterized using polymerase chain
reaction (PCR) with IS900 MAP-specific primers.
Results: Using all diagnostic modalities, MAPand/or MAPantibodies were identified in 100% (5/5)
of subjects with Crohn’s disease; 75.0% (6/8) of attendants of MAP infected animals were positive
and 38.0% (27/71) of apparently normal controls were also positive. Most sensitive test was ELISA
(100%, 5/5), followed by culture (80.0%, 4/5), and acid-fast staining. Ziehl—Neelsen staining was
positive in 37.5% (3/8) of subjects with active animal husbandry practices. In 71 serum samples
from control subjects, seroprevalence of MAP was 38.0% using indigenous protoplasmic antigens
(PPA) and 36.6% using commercial PPA. Of the serum samples from the Crohn’s disease patients,
100% (5/5) were positive by ELISA using indigenous PPA and 40.0% (2/5) were positive by ELISA
using commercial PPA. IS900 PCR was used to characterize tiny colonies of MAP that grew
extremely slowly on Herrold’s egg yolk medium, and of 15 (42.8%) cultures, 14 (93.3%) were typed
as MAP.* Corresponding author. Tel.: +91 565 2763260x269; fax: +91 565 2763246.
E-mail address: shoorvir.singh@gmail.com (S.V. Singh).
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Conclusions: Paper documented the presence of MAP in all patients with Crohn’s disease, in some
animal attendants who had the history of working with goat herds infected with Johne’s disease
and in few normal healthy individuals. Presence of Ziehl Neelsen positive MAP. In the stool of
attendants working with MAP-infected animals was unique to humans. ELISA based on antigens
derived from indigenous MAP ‘bison type’ genotype of goat origin was most sensitive modality for
screening Crohn’s disease patients.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
In India, (most populous country in the world after China),
enteric infections are the cause of major health problems;
Crohn’s disease was first reported from India in 1986.
Although Mycobacterium avium subspecies paratuberculosis
(MAP) is endemic in the ruminant population of this country,
the association of MAP with enteritis or Crohn’s disease has
not been investigated so far.
Crohn’s diseaseandulcerative colitis, collectively knownas
inflammatory bowel disease (IBD), are complex disorders
reflected by wide variations in clinical practice. IBD has long
beenconsideredtoaffectthepopulationsofNorthAmericaand
Europe more than those of Asia.1 Crohn’s disease was consid-
ered almost non-existent in India until 1986.2 In the last 10
years, however, Crohn’s disease has been reported more fre-
quently from different parts of India, especially the south.3—8
These studies are only tip of the iceberg, since diagnostic
facilities are restricted to few metropolitan cities, but the
largest risk populationsmainly live in villages and small towns.
Abdominal ailments are the leading causes of sickness and
death in large sectionsof the1.2billionplushumanpopulation.
Recently very high prevalence of ulcerative colitis has been
reported from Northern India.9 Pain and frequent bouts of
diarrheaoverlapasclinical signs inmostof thecasesofabdomi-
nal illnesses. Therefore, differential diagnosis between these
two diseases before actual treatment starts, is important.
Though there is no consensus on the etiology of Crohn’s
disease. MAP has been reported from cases of Crohn’s disease
worldwide.10—17 Recently, there has been renewed interest in
the possible association of MAP and Crohn’s disease, largely
due to the isolation of genetically identical pathogenic MAP
from patients with Crohn’s disease.17 Though, Crohn’s disease
was first reported in India in 1986, the association of MAP with
cases of Crohn’s disease has not yet been studied, primarily
due to a lack of indigenous diagnostic kits and reagents. MAP is
endemic in the ruminantpopulationof the country.18—23Apilot
scale study was undertaken to estimate the presence and
association of MAP and antibodies in clinical cases of Crohn’s
disease, in suspected cases of IBD in animal attendants, and in
the healthy humanpopulation, usingmultiple diagnostic tests.
Materials and methods
The presence of MAP was estimated in chronic cases of
Crohn’s disease, in suspected (in-contact) cases of IBD in
animal attendants, and in healthy persons by smear exam-
ination, culture (stool, blood clot, and biopsies), and ELISA
(using indigenous soluble PPA from MAP ‘bison type’ of goat
origin and commercial PPA fromMAP ‘bovine’ genotype). MAP
cultures were characterized using specific IS900 PCR.Biopsies and stool and blood samples
A total of 119 samples (35 stool, 76 serum, three blood clots,
and five biopsies) were collected from 93 healthy persons,
eight animal attendants suffering with long-term colitis
(IBD), and five patients with chronic Crohn’s disease.
Crohn’s disease patients: Samples (stool, blood clots,
serum, and biopsies) were collected from five patients diag-
nosed with chronic Crohn’s disease at the Gastroenterology
Department of All India Institute for Medical Sciences (AIIMS),
New Delhi. These patients were diagnosed on the basis of
history, clinical picture, clinical pathology, and colonoscopy.
Blood samples were also collected from three patients. These
chronic Crohn’s disease patients had no history of contact
with animals and were undergoing treatment for the Crohn’s
disease at AIIMS, New Delhi.
In-contact animal attendants with suspected infection:
Eight stool samples were obtained from animal attendants
who had worked for the past 10—15 years with goatherds
endemic for Johne’s disease19,23—27 and were chronic colitis
patients (suspected for Crohn’s disease on the basis of his-
tory, symptoms, and treatment received at human dispensary
at Central Institute for Research on Goats (CIRG), Makhdoom.
On personal interview they were found to be silently suffer-
ing from sub-clinical and clinical symptoms of IBD and/or
colitis (weight loss, chronic abdominal pain, frequent bouts
of loose motions, reduced appetite, anemia, weakness, ten-
dency to get tired easily). These workers were very poor,
illiterate, and could not afford the cost of medical assis-
tance, therefore, they neither continued with treatment nor
did seek advance medical interventions. These workers also
had their own stock of goats and sheep. Sampling was difficult
since they lost hope of getting cured and only stool samples
were submitted for screening.
Healthy population: Twenty two stool and eight serum
samples were obtained from healthy persons residing in and
around CIRG campus, Makhdoom. Of these persons, one had
been handling cultures of MAP since 1992 and maintained
normal health, while one had history of consuming raw cow’s
milk for few weeks and was suffering from clinical Crohn’s
disease (high erythrocyte sedimentation rate, weight loss,
repeated bouts of loose motions, anemia, low body weight,
unable to take stress, etc.). Sixty three serum samples were
randomly collected from healthy persons in Agra city (North
India), who were easily convinced to volunteer for the study.
Processing of biopsies. stool and blood samples
for isolation of MAP
Approximately 2 g of stool sample was concentrated by
centrifugation and stained with Ziehl—Neelsen (ZN) stain,
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Table 2 Comparisons of smear examination and culture of
stool samples
Culture
positives
Culture
negatives
Smear positivesa 2 1
Smear negatives 13 19
a Ziehl—Neelsen staining.
Table 1 Screening of stool samples by smear examination, culture, and IS900 PCR for the presence of Mycobacterium avium
subspecies paratuberculosis
Study group Stool
samples
Positive in ZN
staining [n (%)]
Positive in
cultures [n (%)]
PCR from MAP
cultures [n (%)]
Crohn’s disease patients a 5 0 4 (80.0) 4 (80.0)
Animal attendants with suspected infectionb 8 3 (37.5) 5 (62.5) 5 (62.5)
Healthy peoplec 22 0 6 (27.2) 5 (22.7)
Total 35 3 (8.5) 15 (42.8) 14 (40.0)
ZN, Ziehl—Neelsen; PCR, polymerase chain reaction; MAP, Mycobacterium avium subspecies paratuberculosis.
a Confirmed cases of Crohn’s disease at the All India Institute for Medical Sciences, New Delhi.
b Working in goatherds endemic for Johne’s disease, and with different degrees of symptoms for colitis or inflammatory bowel disease
(chronic stomach pain, constipation, bouts of loose motions, weakness, tiredness, anemia, etc.).
c Including one laboratory worker who had been culturing MAP since 1992 and one with a history of raw cow’s milk consumption.MAP was isolated as per the method of Whipple and co-
workers28 with some modifications.26 Briefly, 2 g of stool or
2 cubic cm of tissue biopsy or 2 g of blood clot was finely
ground in a sterilized pestle and mortar and suspended in
water. Stool samples were centrifuged and middle layer was
further decontaminated. In biopsies and blood clots the
suspension in water was allowed to stand for 5—6 hours at
room temperature and supernatant was decontaminated in
0.9% hexadecyl pyridinium chloride (HPC) andwere then kept
undisturbed for 12—18 hours at room temperature. The
supernatant was discarded and 0.2 ml of the sediment was
inoculated on slants of Herrold’s egg yolk medium (three
containing mycobactin J and one without mycobactin J).
Antibiotics or anti-fungal agents were not added to the
medium. Slants were incubated at 37 8C and slants were
screened for the appearance of colonies every 15 days.
Enzyme-linked immunosorbent assay (ELISA)
The indigenous ELISA kit initially developed for the screening
of goats27 was standardized for humans. Soluble PPA was
prepared from the native ‘bison type’ genotype of MAP iso-
lated from a terminal case of Johne’s disease in a goat.29 MAP
frequently isolated from the goat, sheep, cattle, and buffalo
populations ofNorth India havebeen genotypedas ‘bison type’
(Whittington RJ, 2001, personal communication).29 Purified
commercial antigen (PPA) of ‘bovine’ MAP was procured from
Allied Monitor, Inc., USA. Antigens from ‘bison type’ and
‘bovine’ MAP were standardized at 0.1 mg and 2.0 mg per well
of themicrotiter plate, respectively. Serumsampleswereused
in 1:50 dilution and anti-human horseradish peroxidase con-
jugate (Sigma) in1:8000dilution. Serum samples fromculture-
positive Crohn’s disease patients and culture-negative healthy
persons were used as positive and negative controls, respec-
tively. Optical densities (OD) were transformed and expressed
as sample-to-positive (S/P) ratios.30
IS900 PCR (Colony PCR)
Positive MAP cultures were processed for DNA isolation as per
van Embden et al.31 and van Soolingen et al.32 DNA was
amplified by PCR using specific IS900 primers.33 The 229-bp
fragment targeting the specific IS900 sequence was amplified
from template DNA. Briefly, in a volume of 50 ml of reaction
mixture, 1 ml of each primer (forward primer: 150 C 24-mer;
reverse primer: 921, 25-mer), 22 ml red dye Master Mix (TaqDNA polymerase, dNTPs, reaction buffer with 1.5 nM magne-
sium chloride), 24 ml de-ionized water, and 2 ml of template
DNA were included (total volume 50 ml). A total of 35 cycles
was performed in a thermocycler (MJ Research) for complete
amplification reaction. The total time taken for 36 cycles was
1.20 h. The reaction conditions were: initial denaturation at
94 8C for 4 min (1 cycle), denaturation at 94 8C for 10 s,
annealing at 61 8C for 10 s, extension at 72 8C for 10 s (35
cycles), and a final extension at 72 8C for 10 min. The presence
and yield of the specific PCR product (229 bp) was analyzed by
1.8% agarose ethidium bromide gel electrophoresis. Positive
(MAP ‘bison type’) and negative (sterile liquipure water) con-
trols were also run to check for contamination.
Results
Smear examinations
Of the smears of stool samples taken from the animal atten-
dants with suspected infection, 37.5% (3/8) were positive for
acid-fast bacilli (AFB) indistinguishable fromMAP. None of the
stool samples from Crohn’s disease patients and healthy
persons was positive for AFB. Cumulatively, of the 35 stool
samples, 8.5% were positive. Of the three positive from the
suspected group, two were also positive in culture of stool
and one case was detected independently (Tables 1 and 2).
Isolation and characterization of MAP colonies
The majority of MAP colonies grew at around 75 days of
incubation on Herrold’s egg yolk medium with mycobactin J
(Allied Monitor, Inc., USA). Primary colonies were identified
on the basis of culture characteristics, bacterial morphology,
slow growth,mycobactin J dependency, acid-fastness, and by
IS900 PCR.
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Figure 1 Mycobacterium avium subspecies paratuberculosis
colonies from stool sample of Crohn’s disease patient (A35).Isolation of MAP from stool samples: Of the 35 stool
samples screened by culture, 15 (42.9%) were positive for
the presence of MAP. (Figure 1). Maximum positives (80.0%)
samples were from the Crohn’s disease patients, followed by
the animal attendants with suspected infection (62.5%) and
healthy persons (27.2%) (Table 1). Animal attendants were
patients with chronic stomach problems (IBD) and had con-
tinuous abdominal pain. In the healthy group, the person
handling MAP cultures and the person with a history of raw
milk consumption were among those with positive cultures.
Isolation of MAP from biopsies of Crohn’s disease patients:
of the five Crohn’s disease patients, four (80.0%) were posi-
tive for MAP in culture of both biopsies and stool samples.
Isolation of MAP from blood clots of Crohn’s disease
patients: Of the three blood clots, two (66.6%) were positive.
These individual were also positive for MAP in stool and biopsy
cultures.Table 3 Screening of stool and serum samples from Crohn’s disease
test kit
Lab code Age
(years)
Sex ZN
staining
Stool
culture
IS9
PC
A35 35 F  + +
A42 42 M  + +
A45 35 M  + +
A49 32 M   
A53 30 M  + +
ZN, Ziehl—Neelsen; PCR, polymerase chain reaction; PPA, protoplasmic
M, male; F, female.
a Diagnosed and undergoing treatment at the Gastroenterology DepaComparison of smear examination and stool culture: Of
the 35 stool samples, 8.5% and 42.8% were positive in smear
examination and culture, respectively. The 5.7% of samples
were positive by two tests and 54.2% of samples were nega-
tive in the two tests. The 2.8% and 37.1% of samples were
positive independently in smear examination and culture,
respectively. Cumulatively, two tests detected 45.7% stool
samples as positives (Table 2).
ELISA
All five Crohn’s disease patients were positive by ELISA using
indigenous PPA, whereas in commercial PPA only two were
positives. The indigenous antigen (PPA) had better correla-
tion with culture (stool and biopsies) from Crohn’s disease
patients (Table 3). In healthy persons and Crohn’s disease
patients, seroprevalence of MAP was 42.1% [(32/76) using
indigenous PPA] and 40.8% [(31/76) using commercial PPA].
Cumulatively, the two antigens detected 57.8% (44/76) of
persons as positives (Table 4). Only 25.0% of serum samples
were positive by both antigens. The 15.7% of serum samples
were positive exclusively by indigenous PPA and 17.1% were
positive exclusively by commercial PPA (Table 4).
Polymerase chain reaction (PCR)
Of the 21 cultures (15 stool samples, four biopsies, and two
blood clots) processed for DNA isolation and IS900 PCR, 20
(95.2%) were amplified giving the specific 229-bp PCR product
(Figure 2). All the cultures from Crohn’s disease patients and
animal attendants with suspected infection were character-
ized as MAP. Of the six cultures from healthy persons, five
(83.3%) were positive (Table 1).
Discussion
There is increasing evidence that Crohn’s disease may have
an infectious etiology, and the most plausible candidate is
MAP. Intriguingly, Koch’s postulates have been fulfilled for
MAP and Crohn’s disease, though they have not been met for
Mycobacterium leprae and leprosy.34 The problems in diag-
nosing MAP infections in humans are primarily due to diffi-
culties in growing MAP in vitro.35 Achieving growth in artificial
medium may be even more difficult when the organism ispatientsa by smear examination, culture, IS900 PCR, and ELISA
00
R
Plate ELISA kit
PPA from MAP ‘bison
type’ strain (indigenous)
PPA from MAP ‘bovine’
strain (commercial)
+ +
+ 
+ 
+ 
+ +
antigens; MAP, Mycobacterium avium subspecies paratuberculosis;
rtment of the All India Institute of Medical Sciences, New Delhi.
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Table 4 Comparative evaluation of protoplasmic antigens of Mycobacterium avium subspecies paratuberculosis (MAP) ‘bison
type’ and MAP ‘bovine’ origin for the sero-diagnosis of antibodies against MAP by ELISA test
Positives with PPA ‘bison type’ Negatives with PPA ‘bison type’
Positives in PPA ‘bovine’ strain 19 12
Negatives in PPA ‘bovine’ strain 13 32
PPA, protoplasmic antigens.initially in its cell-wall-deficient form.35—37 The present study
has also revealed that MAP colonies of human origin are
highly fastidious and extremely slow growing — only tiny
colonies were visible even after prolonged incubation. None
of the stool samples from Crohn’s disease patients and
healthy persons was positive in ZN staining. The presence
of ZN negative MAP in Crohn’s disease patients is compatible
with the theory that MAP in man is present in the cell-wall-
deficient form (spheroplasts) frequently reported in the
literature.36,38 Interestingly three of the eight stool samples
from the animal attendants working with goatherds endemic
for Johne’s disease were ZN positive. Prior to this report
there was only one report of ZN positive IS900 geno-typed
MAP, identified in a hemophiliac man with AIDS.39 The ZN
positive animal attendants with suspected infection may be
indicative of recent feco-oral contamination from goats with
Johne’s disease, or these animal attendants may have fecal—
oral contamination in addition to chronic ZN-MAP infection as
revealed by symptoms of chronic colitis. ZN positive colonies
grew faster than ZN negative colonies.
In culture, 42.8% stool samples were positive for MAP
infection. The presence of MAP was highest in Crohn’s disease
patients, followed by animal attendants with suspected
infection and healthy persons. The recovery of MAP from
biopsies and stool samples of Crohn’s disease patients con-
firmed the association between MAPand Crohn’s disease. The
high presence of MAP in animal attendants correlated withFigure 2 IS900 PCR products obtained with the DNA from stool
and biopsy culture positive isolates. Lane 1: marker (100-bp
ladder); lane 2: A43 (DNA from Crohn’s disease patient biopsy
culture); lane 3: A54 (DNA from Crohn’s disease patient biopsy
culture); lane 4: A38 (DNA from Crohn’s disease patient blood
clot culture); lane 5: A35 (DNA from Crohn’s disease patient stool
culture); lane 6: positive control (‘Bison type’ Mycobacterium
avium subspecies paratuberculosis DNA); lane 7: negative con-
trol (deionized distilled water); lane 8: A13 (DNA from a sus-
pected patient stool culture); lane 9: A14 (DNA from a suspected
patient stool culture); lane 10: A17 (DNA from a suspected
patient stool culture); lane 11: CDF1 (DNA from a healthy person
stool culture); lane 12: CDF2 (DNA from a healthy person stool
culture).the high prevalence of MAP in goatherds.19,23—25,27 Atten-
dants may have contracted infection from endemic herds.
The isolation of MAP from 27.2% of healthy persons may be
due to the high presence of MAP in the environment. Of the
three persons detected in the healthy group, one had been
handling MAP cultures since 1992 and one had a history of raw
cow’s milk consumption and typical clinical symptoms of
Crohn’s disease. Fourteen of the 15 positive cultures were
IS900 positive by PCR (colony PCR).
This study revealed high presence of MAP in North Indian
human population with and without Crohn’s disease. Similar
high prevalence of MAP has been reported in Crohn’s disease
patients and controls by other workers.13,17,40,41 Sensitivities
of culture and ELISA were similar for the detection of MAP in
humans. Sanderson et al.42 reported that culture was less
sensitive as compared to PCR. IS900 PCR has frequently been
used to confirm MAP in cases of Crohn’s disease and controls.
Mishina et al.43 employed reverse transcriptase PCR using
MAP-specific primers (IS900) on total RNA from ileal mucosal
specimens of Crohn’s disease patients and controls with
ulcerative colitis and colon cancer. Bull et al.13 showed that
the detection rates for MAP in Crohn’s disease depended
critically on the validation of the methods used. High propor-
tions of MAP have been reported by using improved culture
and IS900 PCR.44 When these tests are optimal almost every-
body with Crohn’s disease could be found to be infected with
MAP.45 The presence of MAP colonization of the gut in a
minority proportion of persons without Crohn’s disease is
consistent with widespread environmental exposure to these
pathogens, as exemplified also in the population biology of
Mycobacterium tuberculosis, Streptococcus pneumoniae,
Neisseria meningitidis, and Helicobacter pylori.45
In a significant finding, MAP was isolated from two of three
blood clots left after harvesting of serum from Crohn’s dis-
ease patients. These individual were also positive in biopsy
and stool cultures. In a study on MAP bacteremia, Naser
et al.14 cultured MAP from the blood of 14 (50.0%) patients
with Crohn’s disease and two (22.0%) with ulcerative colitis.
Presence of MAP in blood from patients with Crohn’s disease
should not be surprising since in animals with Johne’s disease,
MAP infection is systemic.46 MAP is secreted into milk47 and
infiltrates the extra-intestinal tissues and the bloodstream of
animals.46 Viable MAP has been cultured from commercial
pasteurized milk in UK48 and USA,49 and from potable chlori-
nated municipal water in USA.43 These may be potential
sources of MAP, if it is eventually accepted that MAP is
zoonotic.50 MAP has also been cultured from the milk of
two women with active Crohn’s disease.51
As reported by Bernstein et al.,30 the goat ELISA27 initially
developed for screening of goats for Johne’s disease was
successfully adapted to screen human beings. Using two
antigens of animal origin (goat and bovine), the seropreva-
lence of MAP was high in human subjects from North India,
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ever, indigenous antigen was superior to commercial antigen
in detecting MAP in Crohn’s disease patients. Uniquely,
agreement between the two antigens was high when used
in human subjects, but was either low or nil when used in
goats27 and buffaloes.52 Similar to the present findings,
Chiodini et al.10 reported significantly higher levels of IgG
antibodies to MAP lysate in animal attendants than in healthy
humans. In animals, culture was the most sensitive of the
multiple diagnostic tests used,53 and positives in ELISA were
always lower than in culture.52,53 Though Hermon-Taylor
reported 28 different strains of MAP and some specific to
particular species like sheep and cattle,12 in North India, MAP
‘bison type’ was the most prevalent genotype in animals.52,53
Collins et al.40 detected MAP in significantly higher numbers
of patients with Crohn’s disease than in controls. Similarly in
this study, all the Crohn’s disease patients were positive by
ELISA as compared to 80.0% by culture. Bernstein et al.30 in a
population-based study, reported 35.0% seropositivity rates
for all groups, unlike the present findings and there was no
difference in rates between Crohn’s disease patients, ulcera-
tive colitis patients, and healthy controls or non-affected
siblings. Though BCG vaccination status for randomly
selected individuals was not known, Collins et al.40 showed
that BCG vaccination did not affect the level of serum anti-
body to MAP. BCG vaccination is, however, not popular in
India. High presence of MAP was recorded in culture and all
the isolates were characterized as MAP using IS900 PCR.
Similarly Collins and co-workers,40 in a subset of IBD patients,
reported association with MAP or similar fastidious mycobac-
terial species. A reported case control colonoscopy plus
biospy study of a nested cohort of the study population with
a nested PCR for MAP revealed a positive rate of 32.0% among
controls,54 a rate that is comparable to the seropositive rate
in another study.30 A PCR study from the UK reported a
positive rate of 26.0% in control tissues.13
Presence of MAP in pasteurized milk supplies may be an
important link to the high presence in humans.48,55,56 Wide-
spread infection with MAP in domestic animals has been
reported in the Agra region of North India.18,19,23—27,52,53
An additional potential source for humans to contract MAP
infection is from drinking water.43 High (21.0—70.0%) herd
prevalence of MAP has been reported from Western Europe
and Northern America.12 Therefore, either in the food chain
or in water supplies, it is inevitable that humans sharing the
same geographic areas with animals that are extensively
infected, are regularly exposed to MAP. This first Indian study
is in agreement to some extent with the observations of
Hermon-Taylor and co-workers44 that ‘‘problems caused by
MAP constitute a public health issue’’.
Conclusions
IS900 characterization of positive cultures in stool and biop-
sies from confirmed cases of Crohn’s disease conclusively
prove the association between MAP and Crohn’s disease. The
positive cultures from animal attendants with suspected
infection and healthy persons confirm the high presence of
MAP in the investigated human population of North India. This
is the first report of ZN positive forms of MAP in animal
attendants. MAP was detected in all the Crohn’s disease
patients by ELISA using indigenous PPA. The high reactivityof commercial PPA indicated involvement of a different
genotype in humans. Indigenous PPA from MAP ‘bison type’
genotype of goat origin can be useful in screening for Crohn’s
disease. This study is the first to report on association
between MAP and Crohn’s disease in India. High presence
of MAP in animal attendants and healthy persons shows that
besides association with Crohn’s disease, MAP may also play a
role in cases of colitis and other abdominal ailments in India.
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